US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 2.630
- +0.130+5.20%
Close Dec 26 16:00 ET
- 2.600
- -0.030-1.14%
Post 19:07 ET
548.74MMarket Cap-3.70P/E (TTM)
2.670High2.430Low4.14MVolume2.460Open2.500Pre Close10.63MTurnover2.03%Turnover RatioLossP/E (Static)208.65MShares3.17952wk High13.99P/B536.62MFloat Cap0.30452wk Low--Dividend TTM204.04MShs Float51.375Historical High--Div YieldTTM9.60%Amplitude0.291Historical Low2.567Avg Price1Lot Size
Sangamo Therapeutics Key Stats
EPS
According to the latest financial report of Sangamo Therapeutics, the latest earnings per share (TTM) for the company is 0.04. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Sangamo Therapeutics's free cash flow? The latest report shows it as 11.64M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Sangamo Therapeutics shows that the company's current ratio is 1.35, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Sangamo Therapeutics, the quick ratio is 1.15, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Sangamo Therapeutics? The latest ROE figure is 29.88%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Sangamo Therapeutics, the total asset return on investment (ROA) is 9.19%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Sangamo Therapeutics's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Sangamo Therapeutics, the net profit margin is 21.60%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Heat List
US
Overall
Symbol
Price
% Chg
No Data
